Abstract

Cigar smoking is a type of tobacco smoking: the burning of tightly rolled whole-leaf tobacco whose alkaline smoke is classically drawn into the mouth but not inhaled. That single fact—no inhalation—places cigars at the slow end of the spectrum cognitive psychology uses to explain why tobacco products differ in addictiveness. Because cigar smoke is alkaline, its nicotine is absorbed slowly across the lining of the mouth rather than delivered as a fast pulmonary spike, so under the rate hypothesis it reinforces less strongly than an inhaled cigarette. Yet slower is not safer: cigars still produce dependence and carry substantial cancer risk. This article develops the cognitive account—delivery kinetics, the pH chemistry behind buccal absorption, and the dissociation between how addictive a product is and how harmful—through a worked example and three interactive demonstrations.

Keywords: nicotine, addiction, reward learning, buccal absorption, cessation

Few products make the central cognitive lesson of tobacco so vivid as the cigar. It carries the same drug as a cigarette, often far more of it, yet it is reliably less addictive—and the reason is not the tobacco but the way the nicotine arrives. The classic cigar smoker does not inhale. The alkaline smoke is held in the mouth, some of its nicotine crossing the oral lining slowly, and that slow arrival is read by the brain's reward system as a weaker reinforcer than the fast arterial spike an inhaled cigarette delivers.

This article treats cigar smoking as cognitive psychology treats any drug habit: as a learned behavior shaped by the kinetics of reward rather than by the chemistry of the drug alone. The cigar is the instructive case because it holds the molecule constant and varies the delivery, and in doing so it separates two things that are easy to confuse—how strongly a product addicts, and how badly it harms. Cigars score lower on the first and far from zero on the second, and keeping the two apart is the whole point.

Key Takeaways
  • Cigar smoking is a form of tobacco smoking in which whole-leaf tobacco is burned and its smoke drawn into the mouth—classically without inhalation.
  • Cigar smoke is alkaline, so a share of its nicotine is un-ionised and absorbed across the oral mucosa; the uptake is slow and does not require reaching the lungs.
  • Under the rate hypothesis, this slow buccal delivery reinforces less strongly than the steep pulmonary spike of an inhaled cigarette, which is why classic cigar use is less addictive at an equal or larger dose.
  • Lower addictiveness is not lower harm: exclusive non-inhaling smokers still show elevated mortality from cancers of the mouth, throat, and other sites.
  • Addictiveness and disease risk are dissociable properties of a product—the first set largely by delivery rate, the second by the toxins in the smoke and where they land.

What Cigar Smoking Is

A cigar is a roll of cured, fermented whole-leaf tobacco wrapped in a tobacco leaf, burned at one end while its smoke is drawn through the other. In the Medical Subject Headings vocabulary, Cigar Smoking is a narrower descriptor beneath Tobacco Smoking, and it is defined less by the tobacco than by how that tobacco is used: the smoke is taken into the mouth and, in the classic pattern, not inhaled into the lungs (West, 2017).

That defining habit—mouth, not lung—follows from chemistry. The fermentation that cures cigar tobacco leaves its smoke alkaline, and in alkaline smoke a large fraction of the nicotine is un-ionised, the chemical form that crosses biological membranes freely. Un-ionised nicotine can therefore be absorbed directly across the lining of the mouth, so a cigar smoker does not need to inhale to take up the drug (Benowitz et al., 2009). A cigarette, by contrast, burns acidic tobacco whose nicotine is mostly ionised and poorly absorbed in the mouth; it must reach the vast surface of the lungs, which is why cigarette smokers inhale and cigar smokers traditionally do not.

The consequence for the brain is a matter of timing. Nicotine is an agonist at nicotinic acetylcholine receptors, and its activation of dopamine neurons in the midbrain drives release in the mesolimbic reward pathway (Wittenberg et al., 2020; Dani & Balfour, 2011). The same dopamine signal underlies every tobacco habit; what differs between a cigar and a cigarette is not whether that signal fires but how sharply. Buccal absorption delivers nicotine as a slow swell over minutes; pulmonary absorption delivers it as an arterial bolus within seconds (Benowitz, 2010). The dose can be larger in the cigar; the leading edge is far gentler.

Figure 1

Two Routes, One Molecule

The buccal and pulmonary routes by which nicotine from cigar and cigarette smoke reaches the brain A diagram contrasting two paths. The upper path, labelled cigar, runs from alkaline smoke through the oral mucosa as slow absorption to a gentle rise in brain nicotine. The lower path, labelled cigarette, runs from acidic smoke through the lungs as a fast arterial bolus to a steep rise in brain nicotine. Both paths end at a box labelled dopamine reward. dopamine reward Cigar (not inhaled) alkaline smoke → oral mucosa → slow rise Cigarette (inhaled) acidic smoke → lungs → fast arterial spike same molecule, different leading edge
Note. The cigar and the cigarette carry the same drug to the same reward pathway, but by different routes. Alkaline cigar smoke allows slow buccal uptake without inhalation; acidic cigarette smoke requires fast pulmonary uptake. The rate of arrival, not the dose, is what most distinguishes their addictive power. Schematic, after Benowitz et al. (2009) and Benowitz (2010).

The two routes can be set side by side on every feature the cognitive account turns on (Table 1). Reading across a row makes the central point concrete: the cigar and the cigarette share a drug and differ on almost everything that governs how it is taken up and how strongly it reinforces.

Table 1

The Cigar and the Cigarette Compared on the Features That Set Addictiveness and Harm

Feature Cigar (not inhaled) Cigarette (inhaled)
Smoke pH Alkaline (about 8) Acidic (about 6)
Nicotine form in smoke Largely un-ionised, membrane-permeant Largely ionised, poorly absorbed in the mouth
Main absorption site Oral mucosa (buccal) Lung (pulmonary)
Speed of the rise in brain nicotine Slow—minutes Fast—seconds
Relative reinforcement Lower at an equal or larger dose Higher
Principal site of disease Mouth, throat, and esophagus Lung, with mouth and throat also exposed

Note. The alkaline/acidic contrast and its absorption consequences follow Benowitz et al. (2009); the reinforcement contrast follows the rate hypothesis (Russell, 1990; Benowitz, 2010); the disease-site contrast follows Henley et al. (2004) and Wald & Watt (1997).

Cigar Smoking and Cognition

Cognitive psychology studies cigar smoking through the same systems that carry any nicotine habit—reward learning, attention, and choice—but the cigar earns its own treatment because it sits at the revealing end of each. It is the natural control condition for the cigarette: hold the drug fixed, slow its delivery, and watch the addiction weaken without vanishing. Three ideas organise the account: that the rate of delivery sets reinforcement, that the pH of the smoke sets the rate, and that reinforcement and harm come apart.

The rate hypothesis at the slow end

The central cognitive-pharmacological idea in all of tobacco smoking is the rate hypothesis: the reinforcing power of a dose of nicotine depends on how quickly it reaches the brain, not merely on how much arrives. A sharp spike produces a tight, salient pairing between the act and the dopaminergic reward signal; a slow rise smears that signal across minutes and weakens the association (Russell, 1990; Benowitz et al., 2009). The cigar is the hypothesis's cleanest natural test. Held in the mouth and not inhaled, it delivers nicotine on a time-course measured in minutes rather than seconds, and it is correspondingly less addictive than the inhaled cigarette even when the tobacco it burns contains far more nicotine (Benowitz, 2010).

This reframes the common intuition that a bigger dose must mean a bigger hook. A single large cigar can contain as much nicotine as a pack of cigarettes, yet it does not addict like a pack, because the brain's reward system reads the slope of the rise, not the total eventually absorbed. Demo 1 lets the delivery route be switched between a non-inhaled cigar and an inhaled one and reads off the initial rate of rise that the rate hypothesis says matters.

Demo 1 · How fast does the dose arrive?

Brain nicotine fills toward a peak as C(t) = Cmax(1 − e−t/τ). The non-inhaled cigar delivers across the mouth with a large τ ≈ 6 min; an inhaled puff reaches the brain with a small τ ≈ 0.6 min. The rate hypothesis says the reward system reads the initial slope, Cmax/τ — the same peak dose is far more reinforcing when it arrives steeply.

250ng/mL15 min0half peak4.2 min

■ inhaled τ=0.6  ■ cigar τ=6  ■ your curve

With τ = 6.0 min and Cmax = 25 ng/mL, the initial rate of rise is 4.2 ng/mL per minute. The level reaches half its peak in 4.16 min and 90% in 13.82 min. A slow, cigar-like swell — the same eventual dose, but a shallow rise that is weakly reinforcing.

Note. One-compartment delivery model reproducing the article's Worked Example (cigar τ = 6 min → 4.2 ng/mL·min⁻¹; inhaled τ = 0.6 min → 41.7 ng/mL·min⁻¹ at Cmax = 25) — a tenfold difference in steepness from an identical peak. The rate-of-rise account follows Russell (1990) and Benowitz et al. (2009). Schematic values, not data. Computed locally, not stored.

Alkalinity and the buccal route

Why is cigar smoke absorbed in the mouth at all, when cigarette smoke is not? The answer is acid-base chemistry, and it is worth making explicit because it is the hinge on which the whole cognitive story turns. Nicotine is a weak base; in smoke it exists in equilibrium between an ionised form, which does not cross membranes, and an un-ionised form, which does. The fraction that is un-ionised rises with the pH of the smoke. Cigar tobacco is fermented, and its smoke is alkaline—pH high enough that a substantial share of the nicotine is un-ionised and available for immediate absorption across the oral mucosa (Benowitz et al., 2009).

So the route of delivery, and therefore the addictiveness, is downstream of a single chemical variable. Make the smoke more alkaline and more nicotine can be taken up without inhaling; make it acidic and the smoker must draw it into the lungs to absorb the drug at all. Demo 2 makes this quantitative, plotting the un-ionised fraction against smoke pH so the chemistry behind the cigar's slow buccal route is visible on a curve.

Demo 2 · The chemistry that sets the route

Nicotine crosses the lining of the mouth only in its un-ionised form, and the fraction that is un-ionised rises with the pH of the smoke: f = 1 / (1 + 10(pKa − pH)), with pKa ≈ 8.0. Acidic cigarette smoke (pH ≈ 6) leaves almost none available for oral uptake; alkaline cigar smoke (pH ≈ 8) frees about half. That single variable decides whether the drug can be absorbed without inhaling.

100%0un-ionisedpH 5pH 9.550%cigarettecigar
At pH 8.0, the un-ionised fraction is 50% (50.0% to the decimal). Alkaline, cigar-like smoke: a substantial share is available for buccal uptake, enabling the slow non-inhaled route.

Note. Henderson–Hasselbalch for a weak base, pKa = 8.0, reproducing the Worked Example (pH 6.0 → ≈1%; pH 8.0 → 50%; pH 8.5 → ≈76%). The acid-base control of nicotine uptake follows Benowitz et al. (2009). Schematic, not data. Computed locally, not stored.

Wanting, cues, and the ritual of the cigar

A weaker reinforcer is not a harmless one, and the cigar still recruits the associative machinery of addiction. The incentive-sensitization theory distinguishes two dissociable components of reward: liking, the hedonic pleasure a drug delivers, and wanting, the motivational pull toward it. Repeated use sensitizes the wanting system while liking stays flat or fades, so a smoker can be driven toward a product that no longer delivers much pleasure (Robinson & Berridge, 1993; Berridge & Robinson, 2016).

For the cigar this plays out through its characteristic occasions. Cigars are often tied to distinctive, repeated settings—a celebration, an after-dinner ritual, a particular company—and those settings are exactly the kind of cue that acquires incentive salience and comes to trigger craving on its own (Rose, 2006). Real-time assessment of smokers in their own daily environments confirms that such cues provoke craving episodes outside any deliberate decision to use, which is part of what gives the cigar's ritual its hold (Shiffman et al., 2008). The slower pharmacology blunts how strongly each episode reinforces, but the ritual structure of cigar use can make its cues unusually well-defined. A daily cigar smoker, and especially one who inhales, can develop dependence that looks much like a cigarette smoker's; the gentle delivery lowers the odds of that trajectory without closing it.

Reinforcement is not harm

The cigar's most important cognitive lesson is a dissociation. How addictive a product is and how harmful it is are separate properties, set by different features of the same smoke. Addictiveness tracks the rate of nicotine delivery; harm tracks the dose and destination of tars and carcinogens. Because the classic cigar smoker does not inhale, the worst of the lung exposure is avoided—but the carcinogens still bathe the mouth, throat, and esophagus, and exclusive pipe and cigar smokers show clearly elevated mortality from cancers at those sites and beyond (Henley et al., 2004; Wald & Watt, 1997).

This is why the reassuring phrase at least I do not inhale is half true and dangerously incomplete. Not inhaling genuinely lowers the reinforcement and shifts the disease burden away from the lungs; it does not make the product safe, and the protection collapses the moment a smoker inhales. A product can be less addictive and still deadly, and the cigar is the standing example. Demo 3 places a cigar in a reinforcement-by-harm plane so the two axes can be varied independently and the dissociation seen directly.

Demo 3 · Addictiveness and harm are different axes

The cigar's central lesson is a dissociation. How addictive a product is tracks the rate of nicotine delivery; how harmful it is tracks the dose and destination of its tars and carcinogens. Move the delivery rate and toggle inhalation: the point slides along the two axes independently, so a product can become less reinforcing without becoming less deadly.

reinforcement →harm →non-inhaled cigarinhaled cigarette
At τ = 6.0 min, not inhaled: reinforcement = 32, harm = 42. Not inhaling keeps harm to the oral and upper-airway exposure, but the carcinogens are still there: lower reinforcement, not low harm.

Note. Schematic two-axis model. Reinforcement saturates in the delivery rate 1/τ; harm sums a fixed oral term and a lung term present only when inhaling — the two axes are independent by construction. The site-specific mortality of exclusive cigar and pipe smoking follows Henley et al. (2004) and Wald and Watt (1997). Illustrative values, not data. Computed locally, not stored.

Nicotine, cognition, and dependence

Cigar smokers, like other tobacco users, often report that the drug steadies attention or mood. Acute nicotine does produce small, genuine improvements in sustained attention and response speed in meta-analysis (Heishman et al., 2010). But in anyone who has become dependent, much of the felt benefit is the relief of withdrawal rather than enhancement above a non-user's baseline. As dependence forms, the reward and stress systems shift toward a state in which the drug is needed to feel normal—a move from positive reinforcement toward relief of a drug-created deficit (Koob & Volkow, 2016). Because the cigar delivers nicotine slowly and is often used intermittently, that trajectory is slower and less certain than with cigarettes, but it is the same trajectory, driven by the same pharmacology (Benowitz, 2010).

Worked Example

The cigar's two defining quantities—its slow delivery and the alkaline chemistry behind it—can both be made numerical.

Delivery rate. Model brain nicotine after a dose as a one-compartment system filling toward a peak Cmax with a delivery time constant τ:

C(t) = Cmax (1 − e−t/τ)

The quantity the rate hypothesis says the reward system reads is the initial rate of rise, the slope at the start, which is Cmax / τ. Take the same peak for both routes, Cmax = 25 ng/mL. Give the non-inhaled cigar a buccal time constant τ = 6 min and an inhaled puff a pulmonary τ = 0.6 min:

- Non-inhaled cigar: 25 / 6 = 4.2 ng/mL per minute - Inhaled: 25 / 0.6 = 41.7 ng/mL per minute

A tenfold difference in the steepness of the leading edge from an identical peak dose—the pharmacological core of why not inhaling blunts the hook. The time to reach a fraction f of the peak is t = −τ ln(1 − f), so the non-inhaled cigar reaches half its peak in 6 × 0.693 = 4.16 min, while the inhaled puff reaches half in 0.6 × 0.693 = 0.42 min (about 25 seconds).

Alkalinity. The fraction of nicotine that is un-ionised, and so available for buccal absorption, follows the Henderson–Hasselbalch relation for a weak base of dissociation constant pKa ≈ 8.0:

fun-ionised = 1 / (1 + 10(pKa − pH))

- Acidic cigarette smoke, pH 6.0: 1 / (1 + 102.0) = 1 / 101 = about 1% un-ionised—almost nothing absorbed in the mouth. - Alkaline cigar smoke, pH 8.0: 1 / (1 + 100) = 1 / 2 = 50% un-ionised. - Strongly alkaline smoke, pH 8.5: 1 / (1 + 10−0.5) = 1 / 1.316 = about 76% un-ionised.

From 1% to 50% is a fifty-fold change in the nicotine available for immediate oral uptake, produced by a two-unit shift in pH. That is the chemistry that lets a cigar smoker absorb the drug without inhaling, and so the chemistry that sets the delivery route the rate hypothesis then reads. Demo 1 varies τ and Cmax; Demo 2 varies the pH.

Discussion

Read cognitively, the cigar is less a product than an experiment the world runs for us. It holds nicotine constant and varies its delivery, and in doing so it demonstrates the rate hypothesis more cleanly than any laboratory manipulation: the same molecule, delivered slowly across the mouth instead of swiftly through the lungs, reinforces less and addicts less (Benowitz, 2010; Russell, 1990). The chemistry that makes this possible—the alkalinity that frees nicotine for buccal absorption—shows that the behavior (not inhaling) and the pharmacology (slow uptake) are two faces of a single physical fact (Benowitz et al., 2009).

But the cigar also teaches the limit of that reassurance. Lower addictiveness is not lower harm. The carcinogens in cigar smoke do their damage wherever the smoke lands, and for the non-inhaling smoker that is the mouth and throat rather than the lung—a shift in the site of disease, not an escape from it (Henley et al., 2004; Wald & Watt, 1997). Holding addictiveness and harm apart is the discipline the cigar forces, and it generalises: across the whole landscape of nicotine products, how strongly something hooks and how badly it hurts are set by different variables and must be judged separately.

Current Directions

Two active fronts bear directly on cigar smoking. The first is the regulatory science of how delivery chemistry should be classified and controlled. As cigars, little cigars, and cigarillos proliferate alongside cigarettes and newer nicotine products, the cognitive question—how steeply does the brain level rise, and therefore how reinforcing is the product—now carries direct policy stakes, because a slow-delivery product and a fast one demand different treatment even when their nicotine content is similar (Benowitz, 2010; West, 2017). The second is a deepening neurocircuitry account of how intermittent, slow-delivery use maps onto the reward and stress systems over time: whether occasional cigar use engages the same shift from positive reinforcement toward relief of a drug-created deficit that daily cigarette smoking produces, and if so how quickly, is being traced onto specific circuits (Koob & Volkow, 2016). Underlying both is a sharpening receptor-level picture of how nicotine acts on particular nicotinic acetylcholine receptor subtypes to produce the learned changes that sustain any tobacco habit (Wittenberg et al., 2020).

Common Misconceptions

Cigars are not addictive because people do not inhale.
Not inhaling lowers addictiveness; it does not abolish it. Alkaline cigar smoke lets nicotine be absorbed across the mouth without reaching the lungs, so a cigar smoker still takes up the drug and can still become dependent—especially with daily use or any inhalation (Benowitz et al., 2009; Benowitz, 2010).
A cigar holds more nicotine than a cigarette, so it must be more addictive.
Addictiveness tracks the rate of delivery, not the total dose. A single cigar can contain the nicotine of a whole pack yet addict less, because slow buccal absorption never produces the steep arterial spike that the rate hypothesis identifies as the strongest reinforcer (Russell, 1990).
Because cigars are less addictive, they are safer.
Addictiveness and harm are dissociable. Exclusive non-inhaling pipe and cigar smokers still show elevated mortality from cancers of the mouth, throat, and other sites; not inhaling shifts the disease burden away from the lung rather than removing it (Henley et al., 2004; Wald & Watt, 1997).
A cigar genuinely calms the nerves and sharpens the mind.
Acute nicotine gives small real gains in attention, but in a dependent user most of the felt benefit is relief of the deficits that abstinence itself produces—a repair of a drug-created deficit, not enhancement above baseline (Heishman et al., 2010).

Glossary

Addiction.
A disorder of compulsive drug seeking and use maintained by learned changes in reward, attention, and motivation; in tobacco it is driven by nicotine and the cues paired with it.
Alkaline smoke.
Smoke with a pH high enough that much of its nicotine is un-ionised and can be absorbed across the lining of the mouth; characteristic of cigar and pipe tobacco, allowing uptake without inhalation.
Buccal absorption.
Uptake of a drug across the mucous membrane lining the mouth; for nicotine it is slow relative to the lungs and depends on the un-ionised fraction, and it is the route by which cigar smokers take up the drug without inhaling.
Craving.
An intense, often cue-triggered desire to smoke; in incentive-sensitization theory it is the subjective face of sensitized wanting and can be provoked by the settings and occasions associated with cigar use.
Delivery kinetics.
The time-course over which a drug reaches the brain after a dose; for nicotine, set chiefly by the route of absorption and captured here by the time constant τ.
Dissociation.
The separation of two properties that are easily conflated; here, the fact that how addictive a tobacco product is and how harmful it is are set by different features of the smoke and need not go together.
Henderson–Hasselbalch relation.
The equation linking the ionisation of a weak acid or base to pH; applied to nicotine it gives the un-ionised fraction available for absorption as a function of smoke pH.
Incentive salience.
The motivational property—wanting—that a reward and its cues acquire through conditioning, making them attractive and able to command attention and action independently of pleasure.
Incentive-sensitization.
The theory that repeated drug use sensitizes the brain's wanting system, so cue-driven craving grows and persists while the pleasure (liking) stays flat or fades.
Liking.
The hedonic pleasure a reward delivers, dissociable from wanting; in established tobacco use the liking is often modest even as the wanting remains strong.
Nicotine.
The principal addictive compound in tobacco, an agonist at nicotinic acetylcholine receptors that triggers mesolimbic dopamine release; the same molecule across tobacco products, differing only in how fast it is delivered.
Nicotinic acetylcholine receptor.
The ligand-gated ion channel at which nicotine acts; its activation on midbrain dopamine neurons links the drug to the reward pathway and is the molecular starting point of the habit.
Oral mucosa.
The mucous membrane lining the inside of the mouth, across which un-ionised nicotine from alkaline smoke is absorbed; the site of uptake that makes non-inhaled cigar smoking possible.
Rate hypothesis.
The proposal that the reinforcing power of a drug dose scales with how quickly it reaches the brain, not just with the peak concentration; it explains why slow buccal delivery addicts less than a fast pulmonary spike.
Reinforcement.
The strengthening of a behavior by its consequences; cigar smoking is reinforced by nicotine's reward, more weakly than cigarette smoking because its delivery is slower.
Un-ionised fraction.
The proportion of nicotine in the electrically neutral form that crosses membranes freely; it rises with smoke pH and governs how much nicotine can be absorbed in the mouth.
Wanting.
The motivational pull toward a reward, dissociable from the pleasure it gives; sensitized by repeated drug use and attached to cues, it is the craving that drives tobacco use and relapse.

Key Researchers

Neal L. Benowitz

(Department of Medicine, University of California, San Francisco). The foremost authority on the clinical pharmacology of nicotine, whose work on absorption, metabolism, and the pH-dependence of buccal uptake underpins the rate-based account of why route determines addictiveness. Faculty · Google Scholar · Wikipedia

John A. Dani

(Department of Neuroscience, Perelman School of Medicine, University of Pennsylvania). A leader in the neuroscience of nicotine, whose work connects the action of nicotine at its receptors to the dopaminergic reward signalling that sustains tobacco use. Faculty

Stephen J. Heishman

(National Institute on Drug Abuse, NIH Intramural Research Program). A behavioral pharmacologist whose meta-analytic work established the modest, real—and largely withdrawal-relieving—acute cognitive effects of nicotine and smoking. Faculty

Michael A. H. Russell

(1932–2009) (Addiction Research Unit, Institute of Psychiatry, London). A pioneer of nicotine science who argued that people smoke for nicotine but die from the tar, a formulation that is the cigar's lesson in miniature, and whose work on delivery and dependence laid the groundwork for the rate hypothesis. Wikipedia

Saul Shiffman

(Department of Psychology, University of Pittsburgh). A founder of ecological momentary assessment, who brought the real-time measurement of craving, cue exposure, and lapse into the smoker's own daily environment. Faculty · Google Scholar

Robert West

(Department of Behavioural Science and Health, University College London). A leading figure in the science of tobacco use and cessation, and a longtime editor of the field, whose syntheses frame the health impact, prevalence, and treatment of smoking. Faculty · Google Scholar · Wikipedia

Frequently Asked Questions

Why are cigars less addictive than cigarettes?

Because the nicotine arrives more slowly. Cigar smoke is alkaline, so its nicotine is absorbed gradually across the lining of the mouth rather than inhaled and delivered as a fast arterial spike to the brain. The rate hypothesis holds that a slow rise reinforces the behavior less strongly than a sharp spike, so the classic non-inhaled cigar addicts less than a cigarette even when it carries more nicotine.

Does a cigar contain more nicotine than a cigarette?

Often far more. A single large cigar can hold as much nicotine as a whole pack of cigarettes. What keeps it from addicting like a pack is not the dose but the delivery: slow buccal absorption never produces the steep spike that drives the strongest reinforcement, so the total nicotine present overstates how addictive the product actually is.

If cigar smokers do not inhale, are cigars safe?

No. Not inhaling lowers the reinforcement and moves the main disease burden away from the lungs, but exclusive pipe and cigar smokers still show elevated mortality from cancers of the mouth, throat, and other sites. The carcinogens act wherever the smoke lands, so not inhaling shifts the harm rather than removing it, and the protection disappears the moment a smoker inhales.

Why does the pH of the smoke matter so much?

Because it decides how much nicotine can be absorbed in the mouth. Nicotine crosses membranes only in its un-ionised form, and the fraction that is un-ionised rises steeply with pH. Alkaline cigar smoke has a high enough pH that a large share of its nicotine is available for immediate oral uptake, which is exactly why a cigar smoker can take up the drug without drawing smoke into the lungs.

Can someone become dependent on cigars?

Yes. The slower delivery lowers the odds of dependence but does not prevent it, particularly with daily use or any inhalation. A regular cigar smoker takes up nicotine across the mouth day after day, and the same reward learning that builds a cigarette habit can build a cigar habit, just more gradually.

Do the cues and rituals around cigars matter?

They do. Cigars are often tied to specific occasions and settings, and under incentive-sensitization those repeated pairings let the cues acquire a pull of their own, triggering craving when they recur. The slower pharmacology weakens how much each episode reinforces, but the well-defined ritual structure of cigar use can make its cues unusually distinct.

Does a cigar really help a smoker relax or think more clearly?

Only marginally, and mostly as relief rather than true enhancement. Acute nicotine produces small genuine gains in attention, but in a dependent user much of the felt calm is the reversal of the restlessness and poor concentration that abstinence itself causes. The experience is real, but it is largely the quieting of a deficit the nicotine helps maintain.

Cigar smoking is one form of tobacco smoking, distinguished by how the tobacco is burned and taken up rather than by a different drug. It sits at the slow-delivery end of the same spectrum that runs through pipes and cigarettes, which is what makes it such a clear illustration of the general principle that delivery rate, not the product category, governs how addictive a form of smoking is.

References

Benowitz, N. L., Hukkanen, J., & Jacob, P. (2009). Nicotine chemistry, metabolism, kinetics and biomarkers. In J. E. Henningfield, E. D. London, & S. Pogun (Eds.), Nicotine psychopharmacology (Handbook of Experimental Pharmacology, Vol. 192, pp. 29–60). Springer. https://doi.org/10.1007/978-3-540-69248-5_2

Benowitz, N. L. (2010). Nicotine addiction. New England Journal of Medicine, 362(24), 2295–2303. https://doi.org/10.1056/NEJMra0809890

Berridge, K. C., & Robinson, T. E. (2016). Liking, wanting, and the incentive-sensitization theory of addiction. American Psychologist, 71(8), 670–679. https://doi.org/10.1037/amp0000059

Dani, J. A., & Balfour, D. J. K. (2011). Historical and current perspective on tobacco use and nicotine addiction. Trends in Neurosciences, 34(7), 383–392. https://doi.org/10.1016/j.tins.2011.05.001

Henley, S. J., Thun, M. J., Chao, A., & Calle, E. E. (2004). Association between exclusive pipe smoking and mortality from cancer and other diseases. Journal of the National Cancer Institute, 96(11), 853–861. https://doi.org/10.1093/jnci/djh144

Heishman, S. J., Kleykamp, B. A., & Singleton, E. G. (2010). Meta-analysis of the acute effects of nicotine and smoking on human performance. Psychopharmacology, 210(4), 453–469. https://doi.org/10.1007/s00213-010-1848-1

Koob, G. F., & Volkow, N. D. (2016). Neurobiology of addiction: A neurocircuitry analysis. The Lancet Psychiatry, 3(8), 760–773. https://doi.org/10.1016/S2215-0366(16)00104-8

Robinson, T. E., & Berridge, K. C. (1993). The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Research Reviews, 18(3), 247–291. https://doi.org/10.1016/0165-0173(93)90013-P

Rose, J. E. (2006). Nicotine and nonnicotine factors in cigarette addiction. Psychopharmacology, 184(3–4), 274–285. https://doi.org/10.1007/s00213-005-0250-x

Russell, M. A. H. (1990). The nicotine addiction trap: A 40-year sentence for four cigarettes. British Journal of Addiction, 85(2), 293–300. https://doi.org/10.1111/j.1360-0443.1990.tb03085.x

Shiffman, S., Stone, A. A., & Hufford, M. R. (2008). Ecological momentary assessment. Annual Review of Clinical Psychology, 4, 1–32. https://doi.org/10.1146/annurev.clinpsy.3.022806.091415

Wald, N. J., & Watt, H. C. (1997). Prospective study of effect of switching from cigarettes to pipes or cigars on mortality from three smoking related diseases. BMJ, 314(7098), 1860–1863. https://doi.org/10.1136/bmj.314.7098.1860

West, R. (2017). Tobacco smoking: Health impact, prevalence, correlates and interventions. Psychology & Health, 32(8), 1018–1036. https://doi.org/10.1080/08870446.2017.1325890

Wittenberg, R. E., Wolfman, S. L., De Biasi, M., & Dani, J. A. (2020). Nicotinic acetylcholine receptors and nicotine addiction: A brief introduction. Neuropharmacology, 177, 108256. https://doi.org/10.1016/j.neuropharm.2020.108256